Skip to content

Lavender Aromatherapy for Sleep in Hospitalized Adult Patients

The Effect of Lavender Aromatherapy on Sleep in Hospitalized Adult Patients

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04648215
Enrollment
108
Registered
2020-12-01
Start date
2021-02-22
Completion date
2022-12-31
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep, Hospitalization

Keywords

lavender aromatherapy, sleep

Brief summary

This feasibility study's aim is to determine the effectiveness of lavender oil aromatherapy on quality and duration of sleep in hospitalized adult patients

Detailed description

Hospitalized patients on a medical unit will be randomly assigned to one of three groups of 36 patients: Intervention (Lavender oil), Placebo Intervention (Grapeseed Oil), or Control (Standard of Care). Following a determination of meeting inclusion criteria on admission and completing informed consent, subjects will be randomized to one of three groups on admission. This is a 4 day study with pre- intervention (baseline) sleep data on quality and duration of sleep using the Verrans & Halpern- Snyder Sleep Scale collected on Day 2, following admission day. For the intervention, indirect aromatherapy, a 2x2 gauze with 2 drops of either oil (lavender or grapeseed is pinned it to the subjects' nightgown (right scapula area) for two sequential nights (Time 1 and Time 2) (Day 2 and 3) and removed in the morning after 10 hours . Sleep Quality and Duration are then measured in the morning, Time 1 and Time 2, (Day 3 and Day 4) by the Verran & Snyder-Halpern Sleep Scale analogue. The control group receives standard of care in the evenings and the same data as the intervention groups are collected for sleep quality and duration, pre-intervention and Time 1 and Time 2 .. The differences in the scores for sleep quality and duration will be compared from pre-intervention to Time 1 and Time 2 for each group .

Interventions

aromatherapy--two drops applied to a 2x2 gauze and pinned to subject's gown

aromatherapy--two drops applied to a 2 X 2 gauze and pinned to subject's gown

Sponsors

Northwell Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized three group design : lavender aromatherapy (intervention); grapeseed oil aromatherapy (placebo) ; standard of care for night time (control)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ability to speak, read and understand English. * Ability to use an electronic pad following instruction and assistance for data collection

Exclusion criteria

* Cognitive impairment .Allergy to lavender or grapeseed oil * .Any condition that has been reported to affect the sense of smell * Newly prescribed sleep medications (last two weeks prior to admission) or those causing sleepiness * Pregnancy * Currently using lavender therapy (aroma, massage, etc.). * A smoker of any kind (tobacco, electronic cigarettes) . * History of migraine headaches. * Asthma, Bronchitis, or any airway disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in sleep duration from Baseline to Day 3 and day 4Baseline, Day 3, Day 4Measured by an increase in the mean scores Verans and Snyder-Halpern Sleep Scale (0-100) by 10 or greater
Change in sleep quality from Baseline to Day 3 and Day 4Baseline Day 3, Day 4Measured by an increase in mean scores on the the Verans and Snyder-Halpern Sleep Scale of 10 or greater

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026